Insmed (INSM) Misses Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $124.89 -1.11%
Revenue Growth %: +253.1%
Financial Fact:
Investment income: 138K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +253.1%
Financial Fact:
Investment income: 138K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q4 EPS of ($0.95), $0.05 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $50.78 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Braze stock tumbles 10% on weak third quarter EPS guidance
- BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
